PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 10, 2026Journal of Neuroanaesthesiology and Critical Care0 citationsOpen Access

Intraoperative Central Venous Catheter Usage in Elective Neurosurgery: A Quality Improvement Initiative

View Full Paper
ATA ThomasSRSandra B. RatnamNKNikil Krishnan

Key Points

  • This initiative aimed to improve the choice and usage of central venous catheters (CVCs) in elective neurosurgery while ensuring safety.
  • Three-phase quality improvement study at a tertiary care hospital in South India.
  • Phase 1 assessed CVC usage; Phase 2 involved feedback to the Neuroanaesthesia team; Phase 3 documented changes in practice.
  • Statistical analyses used included χ2, Fisher's exact, and Mann–Whitney U tests.
  • In phase 1, 19% of neurosurgical cases had CVCs, which increased to 24% in phase 3.
  • PICC use rose significantly from 58% to 82%, effectively managing increased inotrope and transfusion needs without complications.
  • Only one catheter-related bloodstream infection occurred in phase 1 with centrally inserted CVCs.

Abstract

Abstract Central venous catheters (CVCs) are routinely used in neurosurgical procedures despite an estimated incidence of line-related complications exceeding 15%. Our quality improvement initiative studied the usage and choice of CVCs and assessed the effect of feedback-based optimization of catheter choice without compromising safety. This 3-phase study was conducted at a tertiary care hospital in South India. It included all patients admitted to the neuro-intensive care unit following elective cranial surgery with intraoperative CVC insertion. Phase 1 (3 months) studied the indication, choice of CVC, and duration of retention. Feedback was provided to the Neuroanaesthesia team, whose independent interpretation and practice modification constituted phase 2. In phase 3, the change in practice was documented. Comparative and subgroup analyses were performed using χ 2, Fisher's exact, and Mann–Whitney U tests. In phase 1, 143 of 769 elective neurosurgical cases (19%) were included, compared with 210 of 869 cases (24%) in phase 3. Despite the significant increase in inotrope and transfusion need in phase 3, peripherally inserted central catheter (PICC) use significantly rose from 58 to 82%, effectively managing such cases with no documented complications. Anticipated blood loss was the most common indication (43%) for line insertion in phase 3. One catheter-related bloodstream infection occurred in phase 1 with a centrally inserted CVC. PICC are safe, cost-effective alternatives to CVCs in elective neurosurgical procedures. A feedback-based quality improvement intervention significantly increased acceptance of PICC without compromising safety or perioperative management of complications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Thomas et al. (2026) studied this question.

synapsesocial.com/papers/6a0020aec8f74e3340f9b902https://doi.org/10.1055/s-0046-1820413
Ask AI
Helpful
Bookmark
Share
View Full Paper